30454-92-3

Usage

Intermediate in pharmaceuticals and agricultural chemicals synthesis

Used as a precursor in the production of various drugs and chemicals used in agriculture.

Raw material for dyes and pigments production

Utilized in the creation of colorants for various industries.

Corrosion inhibitor for lubricating oils

Added to lubricating oils to prevent metal corrosion.

Upstream product

• 35010-32-3 4,5-bis(trifluoromethyl)-2-nitroaniline 

Downstream Products

• 579485-34-0 4-[3-(2-Hydroxymethyl-pyridin-4-yl)-phenyl]-7,8-bis-trifluoromethyl-1,3-dihydro-benzo[b][1,4]diazepin-2-one 
• 579485-32-8 4-[3-(2,6-Dimethyl-pyridin-4-yl)-phenyl]-7,8-bis-trifluoromethyl-1,3-dihydro-benzo[b][1,4]diazepin-2-one 
• 579485-31-7 4-[3-(2-Methyl-pyridin-4-yl)-phenyl]-7,8-bis-trifluoromethyl-1,3-dihydro-benzo[b][1,4]diazepin-2-one 
• 579485-33-9 4-(3-Pyridin-3-yl-phenyl)-7,8-bis-trifluoromethyl-1,3-dihydro-benzo[b][1,4]diazepin-2-one 

Relevant academic research and scientific papers

Glycine receptor antagonists and the use thereof

Methods of treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, as well as treating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease and Down's syndrome, treating or preventing the adverse consequences of the hyperactivity of the excitatory amino acids, as well as treating anxiety, chronic pain, convulsions, inducing anesthesia and treating psychosis are disclosed by administering to an animal in need of such treatment a compound having high affinity for the glycine binding site, lacking PCP side effects and which crosses the blood brain barrier of the animal. Also disclosed are novel 1,4-dihydroquinoxaline-2,3-diones, and pharmaceutical compositions thereof. Also disclosed are highly soluble ammonium salts of 1,4-dihydroquinoxaline-2,3-diones.